Evidence map›Paper›PMID 39963934›Full record

ArticleEuropean journal of breast health2025

Quality of Life and Age-Related Predictor Symptoms in Breast Cancer Survivors Undergoing Hormone Therapy: A Study from the Northern Region of Morocco.

Fadoua El Battioui, Abdelouahid Louazi, Noura Boukil, Zohra Ben Allal, Rajae Alloudane, Said Barrijal

Abstract read
In one paragraph

Article in European journal of breast health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fadoua El BattiouiLaboratory of Biotechnology, Genomic and Bioinformatics, Faculty of Science and Techniques,Tangier, Abdelmalek Essaâdi University, Tetouan, Morocco.ORCID 0000-0002-5069-2899
Abdelouahid LouaziInstitute of Nursing,Tetouan, Morocco.ORCID 0000-0001-7802-0376
Noura BoukilDepartment of Biology and Health, Faculty of Sciences, Abdelmalek Essâadi University, Tétouan, Morocco.ORCID 0009-0003-1478-5494
Zohra Ben AllalFaculty of medicine and pharmacy, Abdelmalek Essaadi University, Tetouan, Morocco.ORCID 0009-0002-0417-7164
Rajae AlloudaneLaboratory of Biotechnology, Genomic and Bioinformatics, Faculty of Science and Techniques,Tangier, Abdelmalek Essaâdi University, Tetouan, Morocco.ORCID 0009-0003-0718-0569
Said BarrijalLaboratory of Biotechnology, Genomic and Bioinformatics, Faculty of Science and Techniques,Tangier, Abdelmalek Essaâdi University, Tetouan, Morocco.ORCID 0000-0002-7616-8331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study was to assess the health-related quality of life (HRQoL) of breast cancer (BC) survivors during adjuvant hormone therapy (AHT) as a function of age and to identify predictor symptoms. Materials and Methods: The study was based on a cross-sectional survey of 216 BC survivors undergoing AHT, in the Northern Region of Morocco. HRQoL was assessed using a validated HRQoL questionnaire, the Functional Assessment of Cancer Treatment (FACT-ES). Multiple linear regression analysis was used to identify predictor symptoms for the subscales of the FACT-ES. Results: Younger women (<45 years) had lower scores on the emotional well-being subscale ( Conclusion: BC survivors' HRQoL during AHT differed by age group. Emotional problems negatively influenced HRQoL in younger women. Knowledge of the symptoms that predict HRQoL in BC survivors may help clinicians develop personalized interventions.

Indexed as

Agebreast cancerhormone therapypredictor symptomsquality of lifesurvivors

Identifiers

PMID39963934
PMCPMC11934820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.